CTLA4 and neoplasm: Inhibitory molecules that hamper anti-tumor immune responses, such as PD-1, PD-L1, and CTLA-4, can be expressed on both tumor cells and various immune cells.76, 77 Blocking these inhibitory molecules has been shown to restore tumor-specific T cell activity.76